06.30.25 -- Does Continuous Complexity Outweigh Its Benefit?

To ensure patient safety — as well as a portable process outside of Europe — it’s time to find a novel reagent without harmful, endocrine-disrupting properties.

MaxCyte's electroporation platform accelerates therapeutic antibody development with scalable, high-efficiency transfection, enabling rapid transient protein expression, and IND-enabling studies in weeks.

Advancements in high-sensitivity residual DNA testing enhance the precision of plasmid DNA purity analysis, ensuring compliance with regulatory standards critical for manufacturing processes.

Gain insight into how UPD ensures scalable and compliant processes, facilitates the efficient development of innovative therapeutics, and contributes to molecule development and production.

From the digital infrastructure needed to enable a collaborative approach, to the quality systems and analytical methods, effective tech transfer relies on the careful consideration of a variety of factors.

Explore temperature effects on product titer, automated cell culture development workflow, maximizing product life-cycle efficiency with the right DOE strategy, and effective data management.

Understand the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.

Improve your cleaning and subsequent sterilization process for your bioreactors, ensuring a thorough cleaning, better reproducibility, and reduced labor.

Learn how to streamline your development timeline and align your project for timely Biologics License Application (BLA) and Investigational New Drug (IND) submissions.